In an exciting turn of events, the Kumar group at the University of Connecticut (UConn) has embarked on a groundbreaking journey into the world of mRNA vaccines, leveraging the power of protein-based nanoparticles to combat a notorious pathogen plaguing the poultry industry. The research, which has been conducted over several years, is a collaborative effort between researchers from UConn’s College of Agriculture, Health and Natural Resources (CAHNR) and College of Liberal Arts and Sciences (CLAS).
This multidisciplinary team, featuring Mazhar Khan, professor in the Department of Pathobiology and Veterinary Science, Challa V. Kumar, emeritus professor in the Department of Chemistry, and graduate students Anka Rao Kalluri and Aseno Sakhrie, has succeeded in overcoming the initial hurdles that this pioneering technology presented.
In a remarkable feat of bioengineering, Kalluri was able to complex the nanoparticles with target mRNA by attaching positively charged amine groups, ensuring successful stabilization. This nuanced approach was validated by detailed studies conducted by Sakharie and colleagues, who demonstrated the effectiveness of these nanoparticle-mRNA complexes in both cellular and animal models.
Their research, published in Vaccines, promises a new weapon against Infectious Bronchitis Virus (IBV), a rapidly spreading coronavirus that has been a thorn in the side of poultry farmers in the U.S and worldwide. The losses poultry farmers incur due to IBV run into millions each year, making the need for an effective solution of paramount importance.
The current combatants against IBV – live attenuated vaccines or killed vaccines – come with their own baggage. The virus could reactivate, mutate, or recombine to create a vaccine-resistant or more virulent strain. These vaccines also have a shorter shelf life and require additional compounds, known as adjuvants, to be effective.
The innovative use of mRNA nanoparticles, however, opens up a new frontier in poultry health management. The promise they hold could revolutionize the industry, enhancing disease resistance in poultry through targeted vaccine delivery. This could pave the way for a more sustainable and efficient poultry industry, providing a beacon of hope in an otherwise challenging landscape.
As the world increasingly leans toward sustainable and efficient practices, the research by the Kumar group is a testament to the transformative power of bioengineering and the potential for mRNA technology in contributing to a more resilient future. Their work stands as an example of the strides being made in the biotech industry, offering a glimpse into a future where such technological breakthroughs become the norm rather than the exception.
Looking ahead, the path is clear: with further research and development, this technology could herald a new era in the battle against poultry diseases, changing the face of the industry and amplifying the potential for global food security.
Read more from miragenews.com
